DekaBank Deutsche Girozentrale - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 158 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.65 and the average weighting 0.4%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,684
-19.7%
53,129
+6.3%
0.00%
-20.0%
Q2 2023$2,096
+18.4%
50,0000.0%0.01%
+25.0%
Q1 2023$1,771
+27.5%
50,000
+25.0%
0.00%0.0%
Q4 2022$1,389
-99.9%
40,0000.0%0.00%
-33.3%
Q3 2022$2,175,000
+27.9%
40,000
+21.2%
0.01%
+20.0%
Q2 2022$1,700,000
-25.7%
33,000
+4.1%
0.01%
-16.7%
Q1 2022$2,288,000
-22.3%
31,700
+26.3%
0.01%
-14.3%
Q4 2021$2,944,000
-12.0%
25,100
+2.4%
0.01%
-22.2%
Q3 2021$3,346,000
-14.3%
24,5000.0%0.01%
-18.2%
Q2 2021$3,905,000
+99.8%
24,500
-7.5%
0.01%
+83.3%
Q1 2021$1,954,000
+91.2%
26,500
+41.0%
0.01%
+50.0%
Q4 2020$1,022,000
+205.1%
18,800
+19.7%
0.00%
+300.0%
Q3 2020$335,000
-32.5%
15,700
-51.8%
0.00%
-50.0%
Q2 2019$496,000
-20.5%
32,600
+63.0%
0.00%
-50.0%
Q1 2019$624,000
+212.0%
20,000
+22.7%
0.00%
+300.0%
Q4 2018$200,000
-67.9%
16,300
-18.5%
0.00%
-75.0%
Q3 2018$624,000
-31.0%
20,000
-40.3%
0.00%
-33.3%
Q2 2018$905,000
+40.3%
33,500
+9.8%
0.01%
+50.0%
Q1 2018$645,000
+748.7%
30,500
+563.0%
0.00%
+300.0%
Q4 2017$76,0000.0%4,6000.0%0.00%0.0%
Q3 2017$76,000
+1.3%
4,6000.0%0.00%0.0%
Q2 2017$75,0004,6000.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders